Taiwan · Delayed Price · Currency is TWD Revivegen Statistics
Total Valuation
Revivegen has a market cap or net worth of TWD 2.01 billion. The enterprise value is 7.66 billion.
| Market Cap | 2.01B |
| Enterprise Value | 7.66B |
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Revivegen has 60.04 million shares outstanding. The number of shares has decreased by -0.42% in one year.
| Current Share Class | 60.04M |
| Shares Outstanding | 60.04M |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | -5.71% |
| Owned by Insiders (%) | 5.76% |
| Owned by Institutions (%) | n/a |
| Float | 31.51M |
Valuation Ratios
The trailing PE ratio is 98.53.
| PE Ratio | 98.53 |
| Forward PE | n/a |
| PS Ratio | 4.29 |
| PB Ratio | 0.81 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 11.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.68, with an EV/FCF ratio of -6.66.
| EV / Earnings | 376.21 |
| EV / Sales | 16.33 |
| EV / EBITDA | 50.68 |
| EV / EBIT | 228.16 |
| EV / FCF | -6.66 |
Financial Position
The company has a current ratio of 0.51, with a Debt / Equity ratio of 2.03.
| Current Ratio | 0.51 |
| Quick Ratio | 0.45 |
| Debt / Equity | 2.03 |
| Debt / EBITDA | 33.27 |
| Debt / FCF | -4.37 |
| Interest Coverage | 1.11 |
Financial Efficiency
Return on equity (ROE) is 0.86% and return on invested capital (ROIC) is 0.38%.
| Return on Equity (ROE) | 0.86% |
| Return on Assets (ROA) | 0.29% |
| Return on Invested Capital (ROIC) | 0.38% |
| Return on Capital Employed (ROCE) | 0.48% |
| Weighted Average Cost of Capital (WACC) | 1.77% |
| Revenue Per Employee | 4.39M |
| Profits Per Employee | 190,336 |
| Employee Count | 107 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 124.12 |
Taxes
In the past 12 months, Revivegen has paid 4.83 million in taxes.
| Income Tax | 4.83M |
| Effective Tax Rate | 18.41% |
Stock Price Statistics
The stock price has increased by +5.39% in the last 52 weeks. The beta is 0.13, so Revivegen's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +5.39% |
| 50-Day Moving Average | 32.81 |
| 200-Day Moving Average | 31.28 |
| Relative Strength Index (RSI) | 48.26 |
| Average Volume (20 Days) | 237,285 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Revivegen had revenue of TWD 469.23 million and earned 20.37 million in profits. Earnings per share was 0.34.
| Revenue | 469.23M |
| Gross Profit | 109.17M |
| Operating Income | 33.58M |
| Pretax Income | 26.25M |
| Net Income | 20.37M |
| EBITDA | 151.17M |
| EBIT | 33.58M |
| Earnings Per Share (EPS) | 0.34 |
Balance Sheet
The company has 349.86 million in cash and 5.03 billion in debt, with a net cash position of -4.68 billion or -77.94 per share.
| Cash & Cash Equivalents | 349.86M |
| Total Debt | 5.03B |
| Net Cash | -4.68B |
| Net Cash Per Share | -77.94 |
| Equity (Book Value) | 2.47B |
| Book Value Per Share | 25.39 |
| Working Capital | -437.93M |
Cash Flow
In the last 12 months, operating cash flow was 172.66 million and capital expenditures -1.32 billion, giving a free cash flow of -1.15 billion.
| Operating Cash Flow | 172.66M |
| Capital Expenditures | -1.32B |
| Depreciation & Amortization | 117.59M |
| Net Borrowing | 1.43B |
| Free Cash Flow | -1.15B |
| FCF Per Share | -19.18 |
Margins
Gross margin is 23.26%, with operating and profit margins of 7.16% and 4.34%.
| Gross Margin | 23.26% |
| Operating Margin | 7.16% |
| Pretax Margin | 5.59% |
| Profit Margin | 4.34% |
| EBITDA Margin | 32.22% |
| EBIT Margin | 7.16% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.49%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.49% |
| Dividend Growth (YoY) | 149.53% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 147.13% |
| Buyback Yield | 0.42% |
| Shareholder Yield | 1.91% |
| Earnings Yield | 1.01% |
| FCF Yield | -57.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.14.
| Last Split Date | Jul 26, 2024 |
| Split Type | Forward |
| Split Ratio | 1.14 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |